Xeris Biopharma Holdings, Inc. (XERS) Net Income by Year
Xeris Biopharma Holdings, Inc. reported $554K in net income in fiscal year 2025. This represents an increase of 101.0% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $17.2M net loss. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Xeris Biopharma Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
XERS Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
XERS Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Xeris Biopharma Holdings, Inc. financials
Frequently Asked Questions
What was Xeris Biopharma Holdings, Inc.'s net income in fiscal year 2025?
Xeris Biopharma Holdings, Inc. reported $554K in net income in fiscal year 2025.
How fast is Xeris Biopharma Holdings, Inc.'s net income growing?
Xeris Biopharma Holdings, Inc. (XERS) net income rose by 101.0% year over year, from -$54.8M to $554K in fiscal year 2025.
What is Xeris Biopharma Holdings, Inc.'s net income over the last twelve months?
Xeris Biopharma Holdings, Inc. (XERS) reported a $17.2M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Xeris Biopharma Holdings, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Xeris Biopharma Holdings, Inc. (XERS) net income went from -$91.1M in fiscal year 2020 to $554K in fiscal year 2025.
What was Xeris Biopharma Holdings, Inc.'s net income in the most recent quarter?
Xeris Biopharma Holdings, Inc. (XERS) reported -$31.1M in net income in Q2 2026. This represents a decrease of 1513.1% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Xeris Biopharma Holdings, Inc. (XERS) reported on that line in every period on record.